PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
Clinical trial NCT00088660 · UNKNOWN
Trial details
- NCT number
- NCT00088660
- Sponsor
- Therion Biologics Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.